Eoin Treacy's view The Danish KFX stock market index is outperforming its regional counterparts as it tests the 2010 and 2011 peaks near 470. While somewhat overbought in the short-term a sustained move below the 200-day MA would be required to question medium-term scope for additional upside.

While the market might previously have been associated with shipping and beer companies, the Index of 30 shares has 6 healthcare stocks representing almost 50% of its market cap.

Novo Nordisk is a European dividend aristocrat yielding 1.57%. It completed at least a partial unwind of the overbought condition relative to the 200-day MA by June before beginning to hit new highs once more. A sustained move below DKK800 would now be required to question the consistency of the medium-term uptrend. Coloplast has a relatively similar pattern,

William Demant Holdings found support from early June above the underlying 18-month range and a sustained move below the 200-day MA would now be required to question medium-term scope for additional upside.